Latest News about LLY
Recent news which mentions LLY
Novo Nordisk Reports Positive Results Of Weight-Loss Drug Liraglutide For Children As Young As 6, Eyes FDA And EMA Approval
September 11, 2024
From Benzinga
From Benzinga
Zepbound And Mounjaro Maker Eli Illy Has A New CFO As It Navigates Regulatory Challenges: What You Should Know
September 09, 2024
From Benzinga
A Glimpse Into The Expert Outlook On Eli Lilly Through 28 Analysts
September 09, 2024
Tickers
LLY
From Benzinga
Tickers
LLY
From Motley Fool
Beyond Mounjaro and Zepbound: 6 Other Drugs That Could Be Blockbusters for Eli Lilly
September 08, 2024
Tickers
LLY
From Motley Fool
Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?
September 07, 2024
From Motley Fool
Innovent Bio hopes for plus-sized profits from obesity drug
September 06, 2024
From Benzinga
FDA Battles Backlog of Drug Factory Inspections Since COVID-19
September 06, 2024
From Benzinga
Stock Of The Day: Here's Why Weight-Loss Drug Maker Eli Lilly Has Reversed
September 06, 2024
Tickers
LLY
From Benzinga
Comparative Study: Eli Lilly And Industry Competitors In Pharmaceuticals Industry
September 06, 2024
From Benzinga
This Big Move by Eli Lilly May Solve the Weight Loss Drug Market's Biggest Problem
September 06, 2024
Tickers
LLY
From Motley Fool
From Benzinga
From Benzinga
Eli Lilly's Once-Weekly Insulin Shows Non-Inferior Blood Sugar Reduction Vs Frequently Used Daily Insulins In Long Term Trials
September 05, 2024
From Benzinga
Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know.
September 05, 2024
From Motley Fool
Why Walgreens Boots Alliance Fell Another 22% in August
September 05, 2024
From Motley Fool
From Benzinga
Trade Pulse Power Inflow Alert: Eli Lilly Stock Rises Over 7 Points
September 04, 2024
Tickers
LLY
From Benzinga
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 03, 2024
From Benzinga
Eli Lilly Launches Discounted Mounjaro And Zepbound As Fight Against Compounded Imitations Escalates Amid Ongoing FDA Shortage Status Debate
September 02, 2024
From Benzinga
2 No-Brainer Growth Stocks to Buy With $1,000 Right Now
September 01, 2024
From Motley Fool
3 No-Brainer Stocks to Buy in September
August 31, 2024
From Motley Fool
From Motley Fool
From Motley Fool
From Benzinga
Novo Nordisk Touts Encouraging Wegovy Data To Lower Risk Of Severe Complications In Heart Failure Patients
August 30, 2024
From Benzinga
Tickers
LLY
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.